What is TB-500?
TB-500 is the research name for a fragment of thymosin beta-4, a protein your body uses in cell movement and repair — it helps cells migrate to where damage is. It's studied for tissue recovery, mostly in preclinical work.
These articles explain the mechanism, review the evidence honestly, and answer the practical questions people bring — dosing, timelines, and how it compares with BPC-157. Prescription-only, with a licensed provider reviewing every request. If you're choosing between TB-500 and BPC-157, the comparison article walks through both.
15 articles on this topic
-
The FDA Peptide Decision Hasn't Been Made Yet
An FDA advisory panel voted on seven peptides in July. Weeks on, nothing has been published — and that gap is the whole story.
-
KLOW Peptide Side Effects: What the Evidence Shows
KLOW peptide side effects do not yet have reliable rates or a complete clinical list. The blend combines four peptides, so its clearest known risks are injection-site reactions, immune reactions, compounding-related problems, and effects that human studies have not measured.
-
KLOW Peptide Benefits: What Each Component Adds
KLOW brings four peptide research rationales into one compounded formulation. The evidence runs from cell studies to animal models, but no clinical trial has tested the finished blend.
-
TB-500 Benefits: What the Evidence Shows
TB-500 benefits are biologically plausible but not established in people. Direct evidence is largely laboratory and animal work on a related actin-binding sequence; the human eye and wound trials tested full-length thymosin beta-4, not systemic TB-500.
-
How Long Does BPC-157 Take to Work?
No human trial establishes a reliable BPC-157 onset. Animal studies measured changes from day 1 through several weeks, but a prescribed course is judged by the specific outcome and follow-up—not a promised start day.
-
Peptides for Joint Pain: What the Evidence Shows
Peptides for joint pain are being studied, but the evidence is mostly cell and animal work. One uncontrolled 16-person knee follow-up is not enough to show that BPC-157, TB-500 or their combination repairs human joints.
-
Thymosin Beta-4: What It Is and How TB-500 Relates
Thymosin beta-4 is a 43-amino-acid protein that helps cells manage actin. TB-500 is a seven-amino-acid synthetic fragment, so research on the parent molecule cannot simply be assigned to the product.
-
TB-500 Side Effects: What Is Known and What Is Not
Most of what circulates as a TB-500 side effect list is neither reported nor ruled out. The honest version starts with how thin the human safety data is — and with why a seller's clean record is not one.
-
BPC-157 and TB-500 Dosage: What Evidence Shows
There is no established human dosing standard for BPC-157, TB-500, or their combination. Published figures come mostly from animals or studies of different molecules and routes.
-
Inside the Glow Peptide Blend
Glow combines three peptides with non-overlapping jobs — BPC-157 signals new blood-vessel growth, TB-500 binds the cell-scaffolding protein actin, and GHK-Cu delivers copper to the enzyme that cross-links collagen.
-
KLOW Peptide Blend: Four Peptides, One Vial
KLOW combines four peptides — BPC-157, TB-500, GHK-Cu, and KPV — in one compounded vial, each mapped to a different phase of tissue repair.
-
BPC-157 Peptide Therapy: Evidence and Limits
BPC-157 has three decades of animal research behind it, one clinical study in the most recent systematic review, and a regulatory status most websites leave out.
-
BPC-157 vs TB-500: How the Repair Peptides Differ
Two peptides studied for tissue repair, two genuinely different mechanisms — and an evidence base that is still almost entirely preclinical. What separates BPC-157 from TB-500, and what neither has been shown to do yet.
-
TB-500 for Injury Recovery, Tissue by Tissue
TB-500 is a synthetic fragment of thymosin beta-4. Human studies of the full-length parent also include intravenous Phase 1 safety and pharmacokinetic trials and topical ophthalmic trials, in addition to Phase 2 chronic-wound studies.
-
Wolverine Peptide Stack: Two Peptides, One Rx
BPC-157 and TB-500 are usually sold together as the Wolverine peptide stack. This is what the published research measured, what it did not, and how a prescription evaluation works.